Journal
Current Treatment Options in Oncology
Publication Date
3-1-2022
Volume
23
Issue
3
First Page
439
Last Page
449
Document Type
Open Access Publication
DOI
10.1007/s11864-021-00928-y
Rights and Permissions
Kasper B, D'Ambrosio L, Davis EJ, Ingham M, Broto JM, Trent JC, van Houdt WJ, Van Tine BA. What Clinical Trials Are Needed for Treatment of Leiomyosarcoma? Curr Treat Options Oncol. 2022 Mar;23(3):439-449. doi: 10.1007/s11864-021-00928-y. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Kasper, Bernd; D'Ambrosio, Lorenzo; Davis, Elizabeth J; Ingham, Matthew; Broto, Javier Martin; Trent, Jonathan C; van Houdt, Winan J; and Van Tine, Brian A, "What clinical trials are needed for treatment of leiomyosarcoma?." Current Treatment Options in Oncology. 23, 3. 439 - 449. (2022).
https://digitalcommons.wustl.edu/oa_4/3033
Department
ICTS (Institute of Clinical and Translational Sciences)
